Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer

Fig. 6

(A) Forest plots of the relationship between hepatocellular carcinoma-modified Gustave Roussy Immune Score and overall survival (I2 = 0.0%, p = 0.582, HR: 2.63, 95% CI: 1.89–3.65, p < 0.001). (B) Sensitivity analysis of the association between hepatocellular carcinoma-modified Gustave Roussy Immune Score and overall survival. HR, hazard ratio; CL, confidence interval

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us